The perspective your science deserves.
MedTech and health tech companies with strong science often stall at the same moment: a product exists, funding is in place, and the right buyers aren't moving. The gap is rarely the technology. It's knowing how serious buyers evaluate it — and what it takes to meet that bar.
Book a Consultation →Technology Assessment
Scientific evaluation of your product against real clinical, commercial, and buyer-readiness criteria. Delivered as a structured written assessment with specific recommendations.
Commercialization Strategy
Which market, which pathway, in what sequence. Built on direct experience from both the manufacturer side and the federal buyer side.
Innovation Program Advisory
For accelerators, health system innovation offices, and institutions building the infrastructure to evaluate and advance MedTech portfolios.
Not sure where to start? That's what the first call is for. Book a time →
Built on materials engineering
Real device experience across drug-device interfaces, biomaterials, polymer engineering, and 3D-printed medical devices.
Tested as the buyer
Four years inside VA, the nation's largest integrated health system, shaping the criteria that determined what got funded, piloted, and adopted.
Every side of the table
From bench science through commercial MedTech programs to federal health innovation. Every stage of the journey, in sequence.